High initiation and persistence on pre-exposure prophylaxis (PrEP) has been documented in pregnant women in Cape Town, South Africa, with 91% of those offered PrEP starting it and nearly half of those continuing to take PrEP six months later. While women who had given birth and those reporting side effects were less likely to stay… Read More »
By Dr. Mercola If you think your birth control pill is the best pregnancy prevention tool there is, you may be surprised by new research looking into its failure rates. Compared to other forms of protection, the Pill failed miserably, which only adds to the myriad of reasons why you should heavily question its use.… Read More »
Prolonged stress can have life-threatening consequences not only for adults but also for children. Research shows adverse childhood experiences (ACEs) can predispose them to any number of health problems later in life. In the early days of mankind’s evolution, the stress response saved our lives by enabling us to run from predators or take down… Read More »
STANS, Switzerland – January 29 2021 – NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) (“NLS” or the “Company”), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces the pricing of its initial public offering of 4,819,277 units at a price… Read More »